Barrett & Company’s ARK Genomic Revolution ETF ARKG Stock Holding History

Barrett & Company’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05K	Hold	25	–	–	﹤0.01%	659
2026 Q1	$661	Hold	25	–	–	﹤0.01%	625
2025 Q4	$724	Hold	25	–	–	﹤0.01%	631
2025 Q3	$694	Hold	25	–	–	﹤0.01%	617
2025 Q2	$609	Hold	25	–	–	﹤0.01%	619
2025 Q1	$519	Hold	25	–	–	﹤0.01%	599
2024 Q4	$589	Hold	25	–	–	﹤0.01%	594
2024 Q3	$640	Hold	25	–	–	﹤0.01%	559
2024 Q2	$587	Hold	25	–	–	﹤0.01%	577
2024 Q1	$719	Hold	25	–	–	﹤0.01%	586
2023 Q4	$820	Hold	25	–	–	﹤0.01%	575
2023 Q3	$697	Hold	25	–	–	﹤0.01%	588
2023 Q2	$852	Hold	25	–	–	﹤0.01%	568
2023 Q1	$752	Hold	25	–	–	﹤0.01%	555
2022 Q4	$706	Hold	25	–	–	﹤0.01%	560
2022 Q3	$706	Buy	+25	New	+$918	﹤0.01%	560

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Barrett & Company's ARKG Position: Q2 2026 in Review

Barrett & Company held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 25 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #659.

Barrett & Company first reported a position in ARKG in Q3 2022 and has held it in 16 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Barrett & Company held 25 shares of ARK Genomic Revolution ETF worth $1.05K as of Q2 2026.
Barrett & Company left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #659 holding.
Barrett & Company first reported a position in ARK Genomic Revolution ETF in Q3 2022 and has held it in 16 quarters since.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.